Patient characteristics
Parameter . | Recombinant asparaginase . | Asparaginase medac . |
---|---|---|
Median age, y; range | 4.5; 2-14 | 4.5; 1-11 |
Median body surface area, m2; range | 0.79; 0.54-1.88 | 0.72; 0.48-1.22 |
Sex: male/female | 9/7 | 8/8 |
Median WBC (×109/L); range | 9.8; 0.7-578.0 | 4.0; 0.6-109.0 |
Median peripheral blasts (%); range | 50.5; 0-96 | 28.0; 0-79 |
Median marrow blasts (%); range | 92.8; 59.2-97.0 | 90.1; 33.8-98.6 |
Immunophenotype (number of patients) | ||
Pro–B-ALL | 1 | 1 |
Common ALL | 8 | 10 |
Pre–B-ALL | 4 | 3 |
T-ALL | 3 | 2 |
Genetics (number of patients) | ||
BCR-ABL | 0 | 1 |
TEL-AML | 5 | 5 |
MLL-AF4 | 0 | 1 |
Other | 9 | 9 |
No aberrations | 2 | 0 |
Parameter . | Recombinant asparaginase . | Asparaginase medac . |
---|---|---|
Median age, y; range | 4.5; 2-14 | 4.5; 1-11 |
Median body surface area, m2; range | 0.79; 0.54-1.88 | 0.72; 0.48-1.22 |
Sex: male/female | 9/7 | 8/8 |
Median WBC (×109/L); range | 9.8; 0.7-578.0 | 4.0; 0.6-109.0 |
Median peripheral blasts (%); range | 50.5; 0-96 | 28.0; 0-79 |
Median marrow blasts (%); range | 92.8; 59.2-97.0 | 90.1; 33.8-98.6 |
Immunophenotype (number of patients) | ||
Pro–B-ALL | 1 | 1 |
Common ALL | 8 | 10 |
Pre–B-ALL | 4 | 3 |
T-ALL | 3 | 2 |
Genetics (number of patients) | ||
BCR-ABL | 0 | 1 |
TEL-AML | 5 | 5 |
MLL-AF4 | 0 | 1 |
Other | 9 | 9 |
No aberrations | 2 | 0 |